Randomized Controlled Trial of Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
Who is this study for? Patients with ulcerative colitis
What treatments are being studied? Sucrosomial Iron
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The aim of the study is to compare the tolerability and efficacy of Sucrosomial Iron to Oral Iron Therapy in a randomized controlled trial for the treatment of Iron Deficiency Anemia in Ulcerative Colitis patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age above 18
• Confirmed diagnosis of Ulcerative Colitis
• Proven Iron Deficiency Anemia (Hb \< 12 for females and Hb \< 13 for males AND iron saturation \<20%)
• Hemoglobin level \> 8g/dl
Locations
Other Locations
Lebanon
American University of Beirut - Medical Center
RECRUITING
Beirut
Contact Information
Primary
Ali El Mokahal, MD
ae136@aub.edu.lb
+961350000
Time Frame
Start Date: 2019-11-04
Estimated Completion Date: 2024-05-04
Participants
Target number of participants: 30
Treatments
Experimental: Sucrosomial Iron
These patients will receive Sucrosomial Iron 30 mg + 70 mg ascorbic acid (Sideral Forte) twice daily
Active_comparator: Oral Iron Therapy
These patients will receive Oral Iron therapy at a dose of 195 mg twice daily for the same period of time
Related Therapeutic Areas
Sponsors
Leads: American University of Beirut Medical Center
Collaborators: Pharma M SAL, Lebanon